Show simple item record

Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro

dc.contributor.authorFunk, Ryan S.
dc.contributor.authorSingh, Rakesh K.
dc.contributor.authorPramann, L.
dc.contributor.authorGigliotti, Nicole M.
dc.contributor.authorIslam, S.
dc.contributor.authorHeruth, D. P.
dc.contributor.authorYe, S. Q.
dc.contributor.authorChan, Marcia A.
dc.contributor.authorLeeder, J. S.
dc.contributor.authorBecker, M. L.
dc.date.accessioned2017-11-06T21:22:11Z
dc.date.available2017-11-06T21:22:11Z
dc.date.issued2016-05-11
dc.identifier.citationFunk, R., Singh, R., Pramann, L., Gigliotti, N., Islam, S., Heruth, D., Ye, S., Chan, M., Leeder, J. and Becker, M. (2016), Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro. Clinical And Translational Science, 9: 149–157. doi:10.1111/cts.12399en_US
dc.identifier.urihttp://hdl.handle.net/1808/25274
dc.description.abstractVariability in response to methotrexate (MTX) in the treatment of juvenile idiopathic arthritis (JIA) remains unpredictable and poorly understood. Based on previous studies implicating an interaction between nicotinamide phosphoribosyltransferase (NAMPT) expression and MTX therapy in inflammatory arthritis, we hypothesized that increased NAMPT expression would be associated with reduced therapeutic response to MTX in patients with JIA. A significant association was found between increased plasma concentrations of NAMPT and reduced therapeutic response in patients with JIA treated with MTX. Inhibition of NAMPT in cell culture by either siRNA-based gene silencing or pharmacological inhibition with FK-866 was found to result in a fourfold increase in the pharmacological activity of MTX. Collectively, these findings provide evidence that NAMPT inhibits the pharmacological activity of MTX and may represent a predictive biomarker of response, as well as a therapeutic target, in the treatment of JIA with MTX.en_US
dc.publisherWileyen_US
dc.rights© 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.		en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_US
dc.titleNicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitroen_US
dc.typeArticleen_US
kusw.kuauthorFunk, Ryan S.
kusw.kudepartmentPharmacy Practiceen_US
dc.identifier.doi10.1111/cts.12399en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail
Name:
Funk_Wiley_2016.pdf
Size:
786.1Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

© 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Except where otherwise noted, this item's license is described as: © 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.